• 中国科技论文统计源期刊（中国科技核心期刊）
  • 中国医药卫生核心期刊
  • 中国抗癌协会系列期刊
中国胸部肿瘤研究协作组（CTONG）
Advanced Search

Personalized Therapy for Lung Cancer
WU Yi-long
2006, 6(1): 1-2. DOI: 10.3969/j.issn.1671-5144.2006.01.001
Abstract PDF
Serial Studies on Relationship between Nucleotide Excision Repair System Gene Expression and Chemotherapeutic Resistance
WU Yi-long, ZHOU Qing
2006, 6(1): 3-6. DOI: 10.3969/j.issn.1671-5144.2006.01.002
Abstract PDF
Circulating Nucleosomes Predict the Response to Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer Reviewed Concurrently with Investigational Strategy for Personalized Therapy of Chemotherapy for Lung Cancer
GU Chun-dong, WANG Zhen
2006, 6(1): 7-9. DOI: 10.3969/j.issn.1671-5144.2006.01.003
Abstract PDF
Erlotinib in Lung Cancer- Molecular and Clinical Predictors of Outcome
ZHANG li, ZHONG Wen-zhao
2006, 6(1): 10-13. DOI: 10.3969/j.issn.1671-5144.2006.01.004
Abstract PDF
Clinical Proteomics Can Be Useful for Classification and Prognosis of Patients with Lung Cancer
LU Shun, LI Rong
2006, 6(1): 14-16. DOI: 10.3969/j.issn.1671-5144.2006.01.005
Abstract PDF
Genomewide cDNA Microarray Screening of Genes Related to Benefits and Toxicities of Platinum-based Chemotherapy in Patients with Advanced Lung Cancer
HAN Bao-hui, ZHANG Xu-chao
2006, 6(1): 17-19. DOI: 10.3969/j.issn.1671-5144.2006.01.006
Abstract PDF
Gene-expression Profiles Predict Survival of Patients with Lung Adenocarcinoma
HE Jie, XU Chong-rui
2006, 6(1): 20-22. DOI: 10.3969/j.issn.1671-5144.2006.01.007
Abstract PDF
The Value of EGFR Mutation and Gene Amplification in Predicting Response to Gefitinib in NSCLC Patients
LI Long-yun, ZHOU Cai-chun, ZHANG Guo-chun
2006, 6(1): 23-27. DOI: 10.3969/j.issn.1671-5144.2006.01.008
Abstract PDF
Combined Bone Substitute and Guided Tissue Regeneration in the Treatment of Intrabony Defects: A Cochrane Systematic Review
TANG Xu-na, QIU Li-hong, ZHOU Bao-sen
2006, 6(1): 28-34. DOI: 10.3969/j.issn.1671-5144.2006.01.009
Abstract PDF
A Meta-analysis on Randomized Controlled Trial of Carvedilol and Labetalol Treatment in Mild and Moderate Hypertension
XUE Qian, LIU Wen-yuan, ZHANG Qian
2006, 6(1): 35-41. DOI: 10.3969/j.issn.1671-5144.2006.01.010
Abstract PDF
A Meta-analyses about Advanced Pancreatic Cancer: Gemcitabine Combined with 5-FU or Capecitabine vs Gemcitabine Alone
GUO Shuang-shuang, WANG Yu, Yang Qiong, XIE De-rong
2006, 6(1): 42-47. DOI: 10.3969/j.issn.1671-5144.2006.01.011
Abstract PDF
Sample-size Estimation for Binary-variable Statistical Inference within Two Groups
LI He, MAI Jing-zhuang, LIU Xiao-qing, RAO Xu-xu
2006, 6(1): 48-51. DOI: 10.3969/j.issn.1671-5144.2006.01.012
Abstract PDF
Discussion for Implement in "China Lung Cancer Practice Guideline"
YU Shi-ying
2006, 6(1): 52-53. DOI: 10.3969/j.issn.1671-5144.2006.01.013
Abstract PDF
NCCN Antiemesis Practice Guidelines
ZOU Yan-mei, YU Shi-ying
2006, 6(1): 54-64. DOI: 10.3969/j.issn.1671-5144.2006.01.014
Abstract PDF

Copyright © 2024 Journal of Evidence-Based Medicine粤ICP备15000268号

Address：Editorial Office of Evidence-based Medicine, Guangdong Provincial People's Hospital, No.123, Huifuxi Road, Guangzhou 510180, China，Tel：020-83844620，E-mail：xzyxzz@163.net